Cardiex
- Short interest
- 0.02%
- +0.02 pp 30d
- as of 24 Jan 2025
- Reported shorts
- 66.7K
- Shares on issue
- 405.231M
Cardiex (CDX) Short Interest
Cardiex (ASX:CDX) had 0.02% of shares reported as short positions as of 24 Jan 2025, representing 66,655 shares. Cardiex operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Cardiex
Cardiex Limited (CDX) specializes in the development and marketing of the SphygmoCor device, a proprietary technology designed for advanced cardiovascular patient assessment and management. This device focuses on measuring central blood pressure and arterial stiffness, offering a more comprehensive view of cardiovascular health than traditional cuff-based measurements. The company aims to provide clinicians with tools to improve diagnostic accuracy and personalize treatment strategies for cardiovascular conditions.
Company profile →Cardiex (ASX:CDX) has 0.02% of its shares on issue reported as short positions as of 24 Jan 2025, or about 66,655 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. CDX is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Latest CDX news
All news- Cleansing Statement
asx · 1 Oct 2026
- Change in substantial holding
asx · 1 Oct 2026
- Appendix 3Y x4
asx · 1 Oct 2026
Company details
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss CDX
Start a research thread or post the first pulse update